POZEN Pharmaceutical Development Company

	June 30, 2009 POZEN Submits New Drug Application For VIMOVO(TM) (PN 400)

	June 09, 2009 POZEN Announces Election of Angela M. Larson to Board of Directors

POZEN is a pharmaceutical company developing products for the treatment
of acute and chronic pain and pain-related conditions.

Citi's Annual Biotech Day Presentation
April 1, 2009

Cowen & Co. 29th Annual Healthcare Conference Presentation
March 16, 2009

Information about POZEN's commitment to Orange County, NC - Habitat for Humanity®

Information on Participating in a
POZEN Clinical Trial

07/02/09 4:00 p.m. ET
NASDAQ: Pozen	$7.51

Change: - 0.22	2.85%
Volume: 91,458